Kat is responsible for Clinical Development at Strata, including oversight of Clinical Development & Operations, Medical Affairs and Regulatory functions. She has extensive regulated product development experience in both drug and diagnostics.
Prior to joining Strata, Kat worked in various Clinical Development roles with increasing responsibilities at Biodesix, Affymetrix, and Eli Lilly & Company.
Kat has an PhD in Epidemiology from Indiana University. Outside of Strata, Kat enjoys endurance running, wine tasting, and relaxing at the beach with family and friends.
